Infectious Diseases and the Kidney in Children

  • Jennifer Stevens
  • Jethro A. Herberg
  • Michael Levin
Living reference work entry


The kidney is involved in a wide range of bacterial, viral, fungal, and parasitic diseases. In most systemic infections, renal involvement is a minor component of the illness, but in some, renal failure may be the presenting feature and the major problem in management. Although individual infectious processes may have a predilection to involve the renal vasculature, glomeruli, interstitium, or collecting systems, a purely anatomic approach to the classification of infectious diseases affecting the kidney is rarely helpful because most infections may involve several different aspects of renal function. In this chapter, a microbiological classification of the organisms affecting the kidney is adopted. Although they are important causes of renal dysfunction in infectious diseases, urinary tract infections and hemolytic uremic syndrome (HUS) are not discussed in detail because they are considered separately in chapters XX and XX, respectively.


Human Immunodeficiency Virus Nephrotic Syndrome Kawasaki Disease Severe Acute Respiratory Syndrome Disseminate Intravascular Coagulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Basu RK, Devarajan P, Wong H, Wheeler DS. An update and review of acute kidney injury in pediatrics. Pediatr Crit Care Med. 2011;12:339–47.PubMedGoogle Scholar
  2. 2.
    Fortenberry JD, Paden ML, Goldstein SL. Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin North Am. 2013;60:669–88.PubMedGoogle Scholar
  3. 3.
    Andreoli SP. Acute kidney injury in children. Pediatr Nephrol. 2009;24:253–63.PubMedCentralPubMedGoogle Scholar
  4. 4.
    De Vriese AS. Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol. 2003;14:792–805.PubMedGoogle Scholar
  5. 5.
    Cohen RI, Hassell AM, Marzouk K, Marini C, Liu SF, Scharf SM. Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med. 2001;164:1890–5.PubMedGoogle Scholar
  6. 6.
    Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 2007;369:836–43.PubMedGoogle Scholar
  7. 7.
    Schneider J, Khemani R, Grushkin C, Bart R. Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med. 2010;38:933–9.PubMedGoogle Scholar
  8. 8.
    Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, Cantaluppi V, Cruz DN, Damman K, Bagshaw SM, et al. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif. 2014;37:271–85.PubMedGoogle Scholar
  9. 9.
    Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27 Suppl 2:B51–63.PubMedGoogle Scholar
  10. 10.
    Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28.PubMedGoogle Scholar
  11. 11.
    Couto-Alves A, Wright VJ, Perumal K, Binder A, Carrol ED, Emonts M, de Groot R, Hazelzet J, Kuijpers T, Nadel S, et al. A new scoring system derived from base excess and platelet count at presentation predicts mortality in paediatric meningococcal sepsis. Crit Care. 2013;17:R68.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Kumar AA, Bhaskar E, Palamaner Subash Shantha G, Swaminathan P, Abraham G. Rhabdomyolysis in community acquired bacterial sepsis–a retrospective cohort study. PLoS One. 2009;4:e7182.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Brandtzaeg P, van Deuren M. Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr Opin Infect Dis. 2002;15:247–52.PubMedGoogle Scholar
  14. 14.
    Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, McCabe C, Welch SB, Whitney A, O’Gara P, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet. 2004;363:203–9.PubMedGoogle Scholar
  15. 15.
    Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med. 2001;345:408–16.PubMedGoogle Scholar
  16. 16.
    Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.PubMedGoogle Scholar
  17. 17.
    Angel C, Shu T, Green J, Orihuela E, Rodriquez G, Hendrick E. Renal and peri-renal abscesses in children: proposed physio-pathologic mechanisms and treatment algorithm. Pediatr Surg Int. 2003;19:35–9.PubMedGoogle Scholar
  18. 18.
    Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet. 1978;312:1116–8.Google Scholar
  19. 19.
    Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs. 2005;7:11–25.PubMedGoogle Scholar
  20. 20.
    Buchdahl R, Levin M, Wilkins B, Gould J, Jaffe P, Matthew DJ, Dillon MJ. Toxic shock syndrome. Arch Dis Child. 1985;60:563–7.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Todd JK, Franco-Buff A, Lawellin DW, Vasil ML. Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome. Infect Immun. 1984;45:339–44.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science (New York, NY). 1990;248:1066.Google Scholar
  23. 23.
    Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202–11.PubMedGoogle Scholar
  24. 24.
    Kaneko J, Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem. 2004;68:981–1003.PubMedGoogle Scholar
  25. 25.
    Malik ZA, Litman N. Perinephric abscess caused by community-acquired methicillin resistant Staphylococcus aureus. Pediatr Infect Dis J. 2007;26:764.PubMedGoogle Scholar
  26. 26.
    Dumitrescu O, Choudhury P, Boisset S, Badiou C, Bes M, Benito Y, Wolz C, Vandenesch F, Etienne J, Cheung AL, et al. Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55:3261–71.PubMedCentralPubMedGoogle Scholar
  27. 27.
    Kambham N. Postinfectious glomerulonephritis. Adv Anat Pathol. 2012;19:338–47.PubMedGoogle Scholar
  28. 28.
    Rodriguez-Iturbe B, Musser JM. The current state of post streptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19:1855–64.PubMedGoogle Scholar
  29. 29.
    Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13:470–511.PubMedCentralPubMedGoogle Scholar
  30. 30.
    Popovic-Rolovic M, Kostic M, Antic-Peco A, Jovanovic O, Popovic D. Medium- and long-term prognosis of patients with acute poststreptococcal glomerulonephritis. Nephron. 1991;58:393–9.PubMedGoogle Scholar
  31. 31.
    Beres SB, Sesso R, Pinto SW, Hoe NP, Porcella SF, Deleo FR, Musser JM. Genome sequence of a Lancefield group C Streptococcus zooepidemicus strain causing epidemic nephritis: new information about an old disease. PLoS One. 2008;3:e3026.PubMedCentralPubMedGoogle Scholar
  32. 32.
    Gnann Jr JW, Gray BM, Griffin Jr FM, Dismukes WE. Acute glomerulonephritis following group G streptococcal infection. J Infect Dis. 1987;156:411–2.PubMedGoogle Scholar
  33. 33.
    Adalat S, Dawson T, Hackett SJ, Clark JE. Toxic shock syndrome surveillance in UK children. Arch Dis Child. 2014;99:1078–82.Google Scholar
  34. 34.
    Rodriguez-Nunez A, Dosil-Gallardo S, Jordan I. Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units. Eur J Pediatr. 2011;170:639–44.PubMedGoogle Scholar
  35. 35.
    Shah SS, Hall M, Srivastava R, Subramony A, Levin JE. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. Clin Infect Dis. 2009;49:1369–76.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, et al. Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis. 2005;192:783–90.PubMedGoogle Scholar
  37. 37.
    Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents. 2001;18:395–8.PubMedGoogle Scholar
  38. 38.
    Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096–100.PubMedGoogle Scholar
  39. 39.
    Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37:333–40.PubMedGoogle Scholar
  40. 40.
    Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O’Rourke K, Talbot J, Low DE. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28:800–7.PubMedGoogle Scholar
  41. 41.
    Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis. 2014;59:358–65.PubMedGoogle Scholar
  42. 42.
    Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis. 2014;59:851–7.PubMedGoogle Scholar
  43. 43.
    Menon K, McNally D, Choong K, Sampson M. A systematic review and meta-analysis on the effect of steroids in pediatric shock. Pediatr Crit Care Med. 2013;14:474–80.PubMedGoogle Scholar
  44. 44.
    Zimmerman JJ. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med. 2007;8:530–9.PubMedGoogle Scholar
  45. 45.
    Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.PubMedGoogle Scholar
  46. 46.
    Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L. Update on Streptococcus pneumoniae associated hemolytic uremic syndrome. Curr Opin Pediatr. 2013;25:203–8.PubMedGoogle Scholar
  47. 47.
    Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955;85:905–9.PubMedGoogle Scholar
  48. 48.
    Seger R, Joller P, Baerlocher K, Kenny A, Dulake C, Leumann E, Spierig M, Hitzig WH. Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion. Helv Paediatr Acta. 1980;35:359–67.PubMedGoogle Scholar
  49. 49.
    von Vigier RO, Seibel K, Bianchetti MG. Positive Coombs test in pneumococcus-associated hemolytic uremic syndrome. A review of the literature. Nephron. 1999;82:183–4.Google Scholar
  50. 50.
    Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol. 2008;23:1951–6.PubMedGoogle Scholar
  51. 51.
    Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr. 2007;151:140–4.PubMedGoogle Scholar
  52. 52.
    Eber SW, Polster H, Quentin SH, Rumpf KW, Lynen R. Hemolytic-uremic syndrome in pneumococcal meningitis and infection. Importance of T-transformation. Monatsschr Kinderheilkd. 1993;141:219–22.PubMedGoogle Scholar
  53. 53.
    Brandt J, Wong C, Mihm S, Roberts J, Smith J, Brewer E, Thiagarajan R, Warady B. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics. 2002;110:371–6.PubMedGoogle Scholar
  54. 54.
    Lai KN, Aarons I, Woodroffe AJ, Clarkson AR. Renal lesions in leptospirosis. Aust N Z J Med. 1982;12:276–9.PubMedGoogle Scholar
  55. 55.
    Abdulkader RC, Silva MV. The kidney in leptospirosis. Pediatr Nephrol. 2008;23:2111–20.PubMedGoogle Scholar
  56. 56.
    Clerke AM, Leuva AC, Joshi C, Trivedi SV. Clinical profile of leptospirosis in South Gujarat. J Postgrad Med. 2002;48:117–8.PubMedGoogle Scholar
  57. 57.
    De Francesco Daher E, Oliveira Neto FH, Ramirez SM. Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis. Rev Inst Med Trop Sao Paulo. 2002;44:85–90.PubMedGoogle Scholar
  58. 58.
    Kennedy ND, Pusey CD, Rainford DJ, Higginson A. Leptospirosis and acute renal failure–clinical experiences and a review of the literature. Postgrad Med J. 1979;55:176–9.PubMedCentralPubMedGoogle Scholar
  59. 59.
    Srivastava RN. Acute glomerulonephritis in Salmonella typhi infection. Indian Pediatr. 1993;30:278–9.PubMedGoogle Scholar
  60. 60.
    Koo JW, Park SN, Choi SM, Chang CH, Cho CR, Paik IK, Chung CY. Acute renal failure associated with Yersinia pseudotuberculosis infection in children. Pediatr Nephrol. 1996;10:582–6.PubMedGoogle Scholar
  61. 61.
    Fukumoto Y, Hiraoka M, Takano T, Hori C, Tsuchida S, Kikawa Y, Sudo M. Acute tubulointerstitial nephritis in association with Yersinia pseudotuberculosis infection. Pediatr Nephrol. 1995;9:78–80.PubMedGoogle Scholar
  62. 62.
    Sato K, Ouchi K, Komazawa M. Ampicillin vs. placebo for Yersinia pseudotuberculosis infection in children. Pediatr Infect Dis J. 1988;7:686–9.PubMedGoogle Scholar
  63. 63.
    Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1:619–20.PubMedGoogle Scholar
  64. 64.
    Latus J, Amann K, Braun N, Alscher MD, Kimmel M. Tubulointerstitial nephritis in active tuberculosis – a single center experience. Clin Nephrol. 2012;78:297–302.PubMedGoogle Scholar
  65. 65.
    Figueiredo AA, Lucon AM, Junior RF, Srougi M. Epidemiology of urogenital tuberculosis worldwide. Int J Urol. 2008;15:827–32.PubMedGoogle Scholar
  66. 66.
    Krishnamoorthy S, Gopalakrishnan G. Surgical management of renal tuberculosis. Indian J Urol. 2008;24:369–75.PubMedCentralPubMedGoogle Scholar
  67. 67.
    Woods CR. Congenital syphilis-persisting pestilence. Pediatr Infect Dis J. 2009;28:536–7.PubMedGoogle Scholar
  68. 68.
    Gamble CN, Reardan JB. Immunopathogenesis of syphilitic glomerulonephritis. Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med. 1975;292:449–54.PubMedGoogle Scholar
  69. 69.
    Cochat P, Colon S, Bosshard S, Zech P, Traeger J. Membranoproliferative glomerulonephritis and Mycoplasma pneumoniae infection. Arch Fr Pediatr. 1985;42:29–31.PubMedGoogle Scholar
  70. 70.
    Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother. 2010;16:162–9.PubMedGoogle Scholar
  71. 71.
    Said MH, Layani MP, Colon S, Faraj G, Glastre C, Cochat P. Mycoplasma pneumoniae-associated nephritis in children. Pediatr Nephrol. 1999;13:39–44.PubMedGoogle Scholar
  72. 72.
    Shah A, Check F, Baskin S, Reyman T, Menard R. Legionnaires’ disease and acute renal failure: case report and review. Clin Infect Dis. 1992;14:204–7.PubMedGoogle Scholar
  73. 73.
    Nishitarumizu K, Tokuda Y, Uehara H, Taira M, Taira K. Tubulointerstitial nephritis associated with Legionnaires’ disease. Intern Med. 2000;39:150–3.PubMedGoogle Scholar
  74. 74.
    Woods CR. Rocky Mountain spotted fever in children. Pediatr Clin North Am. 2013;60:455–70.PubMedGoogle Scholar
  75. 75.
    Quigg RJ, Gaines R, Wakely Jr PE, Schoolwerth AC. Acute glomerulonephritis in a patient with Rocky Mountain spotted fever. Am J Kidney Dis. 1991;17:339–42.PubMedGoogle Scholar
  76. 76.
    Alvarez-Hernandez G, Murillo-Benitez C, Del Carmen Candia-Plata M, Moro M. Clinical profile and predictors of Fatal Rocky Mountain spotted fever in children from Sonora, Mexico. Pediatr Infect Dis J. 2014. Published ahead of print. doi: 10.1097/INF.0000000000000496Google Scholar
  77. 77.
    Conlon PJ, Procop GW, Fowler V, Eloubeidi MA, Smith SR, Sexton DJ. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med. 1996;101:621–6.PubMedGoogle Scholar
  78. 78.
    Gikas A, Kokkini S, Tsioutis C. Q fever: clinical manifestations and treatment. Expert Rev Anti Infect Ther. 2010;8:529–39.PubMedGoogle Scholar
  79. 79.
    Ruiz Seco MP, Lopez Rodriguez M, Estebanez Munoz M, Pagan B, Gomez Cerezo JF, Barbado Hernandez FJ. Q fever: 54 new cases from a tertiary hospital in Madrid. Rev Clin Esp. 2011;211:240–4.PubMedGoogle Scholar
  80. 80.
    Tolosa-Vilella C, Rodriguez-Jornet A, Font-Rocabanyera J, Andreu-Navarro X. Mesangioproliferative glomerulonephritis and antibodies to phospholipids in a patient with acute Q fever: case report. Clin Infect Dis. 1995;21:196–8.PubMedGoogle Scholar
  81. 81.
    Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob Agents Chemother. 2001;45:3644–6.PubMedCentralPubMedGoogle Scholar
  82. 82.
    Levy RL, Hong R. The immune nature of subacute bacterial endocarditis (SBE) nephritis. Am J Med. 1973;54:645–52.PubMedGoogle Scholar
  83. 83.
    Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, Littler WA. Renal pathological findings in infective endocarditis. Nephrol Dial Transplant. 2000;15:1782–7.PubMedGoogle Scholar
  84. 84.
    Baltimore RS. Infective endocarditis in children. Pediatr Infect Dis J. 1992;11:907–12.PubMedGoogle Scholar
  85. 85.
    Rifkinson-Mann S, Rifkinson N, Leong T. Shunt nephritis. Case Rep J Neurosurg. 1991;74:656–9.Google Scholar
  86. 86.
    Vernet O, Rilliet B. Late complications of ventriculoatrial or ventriculoperitoneal shunts. Lancet. 2001;358:1569–70.PubMedGoogle Scholar
  87. 87.
    Haffner D, Schindera F, Aschoff A, Matthias S, Waldherr R, Scharer K. The clinical spectrum of shunt nephritis. Nephrol Dial Transpl. 1997;12:1143–8.Google Scholar
  88. 88.
    Iwata Y, Ohta S, Kawai K, Yamahana J, Sugimori H, Ishida Y, Saito K, Miyamori T, Futami K, Arakawa Y, et al. Shunt nephritis with positive titers for ANCA specific for proteinase 3. Am J Kidney Dis. 2004;43:e11–6.PubMedGoogle Scholar
  89. 89.
    Chan TM. Hepatitis B and renal disease. Curr Hepat Rep. 2010;9:99–105.PubMedCentralPubMedGoogle Scholar
  90. 90.
    Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990;37:663–76.PubMedGoogle Scholar
  91. 91.
    Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noël LH, Trépo C. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine. 1995;74:238–53.PubMedGoogle Scholar
  92. 92.
    van Timmeren MM, Heeringa P, Kallenberg CG. Infectious triggers for vasculitis. Curr Opin Rheumatol. 2014;26:416–23.PubMedGoogle Scholar
  93. 93.
    Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine. 2005;84:313–22.PubMedGoogle Scholar
  94. 94.
    Verma R, Lalla R, Babu S. Mononeuritis multiplex and painful ulcers as the initial manifestation of hepatitis B infection. BMJ Case Rep. 2013;2013. published online. doi:10.1136/bcr-2013-009666. Omit the second 2013.Google Scholar
  95. 95.
    Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24:198–211.PubMedGoogle Scholar
  96. 96.
    Janssen HL, van Zonneveld M, van Nunen AB, Niesters HG, Schalm SW, de Man RA. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol. 2004;16:801–7.PubMedGoogle Scholar
  97. 97.
    Ren J, Wang L, Chen Z, Ma ZM, Zhu HG, Yang DL, Li XY, Wang BI, Fei J, Wang ZG, et al. Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy. J Med Virol. 2006;78:551–60.PubMedGoogle Scholar
  98. 98.
    Elewa U, Sandri AM, Kim WR, Fervenza FC. Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract. 2011;119:c41–9; discussion c49.PubMedGoogle Scholar
  99. 99.
    Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 1995;47:225–30.PubMedGoogle Scholar
  100. 100.
    Shah HH, Patel C, Jhaveri KD. Complete remission of hepatitis B virus-associated nephrotic syndrome from IgA nephropathy following peginterferon therapy. Ren Fail. 2013;35:295–8.PubMedGoogle Scholar
  101. 101.
    Li H, Yuan X, Qiu L, Zhou Q, Xiao P. Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis. Ren Fail. 2014;36:1404–6.PubMedGoogle Scholar
  102. 102.
    Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–14.PubMedGoogle Scholar
  103. 103.
    Jonas MM. Children with hepatitis C. Hepatology. 2002;36:S173–8.PubMedGoogle Scholar
  104. 104.
    Tang SC, Lai KN. Hepatitis C virus-associated glomerulonephritis. Contrib Nephrol. 2013;181:194–206.PubMedGoogle Scholar
  105. 105.
    Rostaing L, Izopet J, Kamar N. Hepatitis C virus infection in nephrology patients. J Nephropathol. 2013;2:217–33.PubMedCentralPubMedGoogle Scholar
  106. 106.
    Stehman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ. Hepatitis C virus-associated glomerulonephritis. Curr Opin Nephrol Hypertens. 1995;4:287–94.PubMedGoogle Scholar
  107. 107.
    Yamabe H, Inuma H, Osawa H, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Shiroto K, Onodera K. Glomerular deposition of hepatitis C virus in membranoproliferative glomerulonephritis. Nephron. 1996;72:741.PubMedGoogle Scholar
  108. 108.
    Batty Jr DS, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant. 2001;1:179–84.PubMedGoogle Scholar
  109. 109.
    Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, et al. The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. Gastroenterology. 2011;140:450–8.e451.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Khaderi S, Shepherd R, Goss JA, Leung DH. Hepatitis C in the pediatric population: transmission, natural history, treatment and liver transplantation. World J Gastroenterol. 2014;20:11281–6.PubMedCentralPubMedGoogle Scholar
  111. 111.
    Beuthien W, Mellinghoff HU, Kempis J. Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature. Clin Rheumatol. 2005;24:507–15.PubMedGoogle Scholar
  112. 112.
    Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK. Widespread presence of histologically occult cytomegalovirus. Hum Pathol. 1984;15:430–9.PubMedGoogle Scholar
  113. 113.
    Beneck D, Greco MA, Feiner HD. Glomerulonephritis in congenital cytomegalic inclusion disease. Hum Pathol. 1986;17:1054–9.PubMedGoogle Scholar
  114. 114.
    Richardson WP, Colvin RB, Cheeseman SH, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, et al. Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med. 1981;305:57–63.PubMedGoogle Scholar
  115. 115.
    Smith JM, Dharnidharka VR. Viral surveillance and subclinical viral infection in pediatric kidney transplantation. Pediatr Nephrol (Berlin, Germany). 2014. published on line. doi: 10.1007/s00467-014-2866-8Google Scholar
  116. 116.
    Onuigbo M, Haririan A, Ramos E, Klassen D, Wali R, Drachenberg C. Cytomegalovirus-induced glomerular vasculopathy in renal allografts: a report of two cases. Am J Transplant. 2002;2:684–8.PubMedGoogle Scholar
  117. 117.
    Ross SA, Novak Z, Pati S, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11:466–74.PubMedCentralPubMedGoogle Scholar
  118. 118.
    Hodson EM, Craig JC, Strippoli GF, Webster AC. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2008;16:CD003774.Google Scholar
  119. 119.
    Alexander BT, Hladnik LM, Augustin KM, Casabar E, McKinnon PS, Reichley RM, Ritchie DJ, Westervelt P, Dubberke ER. Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients. Pharmacotherapy. 2010;30:554–61.PubMedCentralPubMedGoogle Scholar
  120. 120.
    Lin CY, Hsu HC, Hung HY. Nephrotic syndrome associated with varicella infection. Pediatrics. 1985;75:1127–31.PubMedGoogle Scholar
  121. 121.
    Minkowitz S, Wenk R, Friedman E, Yuceoglu A, Berkovich S. Acute glomerulonephritis associated with varicella infection. Am J Med. 1968;44:489–92.PubMedGoogle Scholar
  122. 122.
    Cataudella JA, Young ID, Iliescu EA. Epstein-Barr virus-associated acute interstitial nephritis: infection or immunologic phenomenon? Nephron. 2002;92:437–9.PubMedGoogle Scholar
  123. 123.
    Dylewski J, Roy I, Eid J. Acute renal failure associated with acute Epstein-Barr virus infection. Infect Dis Clin Pract. 2008;16:127–8.Google Scholar
  124. 124.
    Verma N, Arunabh S, Brady TM, Charytan C. Acute interstitial nephritis secondary to infectious mononucleosis. Clin Nephrol. 2002;58:151–4.PubMedGoogle Scholar
  125. 125.
    Okada H, Ikeda N, Kobayashi T, Inoue T, Kanno Y, Sugahara S, Nakamoto H, Yamamoto T, Suzuki H. An atypical pattern of Epstein-Barr virus infection in a case with idiopathic tubulointerstitial nephritis. Nephron. 2002;92:440–4.PubMedGoogle Scholar
  126. 126.
    Bhimma R, Purswani MU, Kala U. Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc. 2013;16:18596.PubMedCentralPubMedGoogle Scholar
  127. 127.
    McCulloch MI, Ray PE. Kidney disease in HIV-positive children. Semin Nephrol. 2008;28:585–94.PubMedCentralPubMedGoogle Scholar
  128. 128.
    Ray PE, Rakusan T, Loechelt BJ, Selby DM, Liu XH, Chandra RS. Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years’ experience. Semin Nephrol. 1998;18:396–405.PubMedGoogle Scholar
  129. 129.
    Wyatt CM, Klotman PE. HIV-1 and HIV-associated nephropathy 25 years later. Clin J Am Soc Nephrol. 2007;2:S20–4.PubMedGoogle Scholar
  130. 130.
    Nebuloni M, Tosoni A, Boldorini R, Monga G, Carsana L, Bonetto S, Abeli C, Caldarelli R, Vago L, Costanzi G. BK virus renal infection in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999;123:807–11.PubMedGoogle Scholar
  131. 131.
    Kopp JB, Falloon J, Filie A, Abati A, King C, Hortin GL, Mican JM, Vaughan E, Miller KD. Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings. Clin Infect Dis. 2002;34:1122–8.PubMedGoogle Scholar
  132. 132.
    Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med. 1999;130:226–30.PubMedGoogle Scholar
  133. 133.
    Turner ME, Kher K, Rakusan T, D’Angelo L, Kapur S, Selby D, Ray PE. A typical hemolytic uremic syndrome in human immunodeficiency virus-1-infected children. Pediatr Nephrol. 1997;11:161–3.PubMedGoogle Scholar
  134. 134.
    Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int. 1999;55:1036–40.PubMedGoogle Scholar
  135. 135.
    Medapalli RK, He JC, Klotman PE. HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens. 2011;20:306–11.PubMedCentralPubMedGoogle Scholar
  136. 136.
    D’Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol. 1998;18:406–21.PubMedGoogle Scholar
  137. 137.
    Wyatt CM, Klotman PE, D’Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol. 2008;28:513–22.PubMedCentralPubMedGoogle Scholar
  138. 138.
    Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D’Agati VD, Klotman PE, Klotman ME. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979–84.PubMedGoogle Scholar
  139. 139.
    Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D’Agati VD, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8:522–6.PubMedGoogle Scholar
  140. 140.
    Jao J, Wyatt CM. Antiretroviral medications: adverse effects on the kidney. Adv Chronic Kidney Dis. 2010;17:72–82.PubMedGoogle Scholar
  141. 141.
    Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Nino MD, Izquierdo MC, Poveda J, Sainz-Prestel V, Ortiz-Martin N, Parra-Rodriguez A, Selgas R, et al. Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat. 2011;2011:354908.PubMedCentralPubMedGoogle Scholar
  142. 142.
    Perazella MA. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int. 2010;78:1060–3.PubMedGoogle Scholar
  143. 143.
    Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children. J Pediatr. 1991;119:710–6.PubMedGoogle Scholar
  144. 144.
    Morales E, Martinez A, Sanchez-Ayuso J, Gutierrez E, Mateo S, Martinez MA, Herrero JC, Praga M. Spontaneous improvement of the renal function in a patient with HIV-associated focal glomerulosclerosis. Am J Nephrol. 2002;22:369–71.PubMedGoogle Scholar
  145. 145.
    Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, Cohen AH, Border WA. Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int. 1999;55:579–92.PubMedGoogle Scholar
  146. 146.
    Ross MJ, Fan C, Ross MD, Chu T-H, Shi Y, Kaufman L, Zhang W, Klotman ME, Klotman PE. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr. 2006;42:1–11.PubMedGoogle Scholar
  147. 147.
    Abbott KC, Trespalacios FC, Agodoa LY, Ahuja TS. HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study. BMC Nephrol. 2003;4:5.PubMedCentralPubMedGoogle Scholar
  148. 148.
    Kimmel PL, Bosch JP, Vassalotti JA. Treatment of human immunodeficiency virus (HIV)-associated nephropathy. Semin Nephrol. 1998;18:446–58.PubMedGoogle Scholar
  149. 149.
    Gruber SA, Doshi MD, Cincotta E, Brown KL, Singh A, Morawski K, Alangaden G, Chandrasekar P, Losanoff JE, West MS, et al. Preliminary experience with renal transplantation in HIV + recipients: low acute rejection and infection rates. Transplantation. 2008;86:269–74.PubMedGoogle Scholar
  150. 150.
    Kumar MS, Sierka DR, Damask AM, Fyfe B, McAlack RF, Heifets M, Moritz MJ, Alvarez D, Kumar A. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int. 2005;67:1622–9.PubMedGoogle Scholar
  151. 151.
    Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014;68 Suppl 1:S2–8.PubMedGoogle Scholar
  152. 152.
    Drachenberg CB, Papadimitriou JC. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis. 2006;8:68–75.PubMedGoogle Scholar
  153. 153.
    Liptak P, Kemeny E, Ivanyi B. Primer: histopathology of polyomavirus-associated nephropathy in renal allografts. Nat Clin Pract Nephrol. 2006;2:631–6.PubMedGoogle Scholar
  154. 154.
    Barraclough KA, Isbel NM, Staatz CE, Johnson DW. BK virus in kidney transplant recipients: the influence of immunosuppression. J Transplant. 2011;2011:750836.PubMedCentralPubMedGoogle Scholar
  155. 155.
    Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol. 2007;22:1243–50.PubMedGoogle Scholar
  156. 156.
    Lin PL, Vats AN, Green M. BK virus infection in renal transplant recipients. Pediatr Transplant. 2001;5:398–405.PubMedGoogle Scholar
  157. 157.
    van Aalderen MC, Heutinck KM, Huisman C, ten Berge IJ. BK virus infection in transplant recipients: clinical manifestations, treatment options and the immune response. Neth J Med. 2012;70:172–83.PubMedGoogle Scholar
  158. 158.
    Emerson LL, Carney HM, Layfield LJ, Sherbotie JR. Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatr Transpl. 2008;12:600–5.Google Scholar
  159. 159.
    Kausman JY. Association of renal adenocarcinoma and BK virus nephropathy post-transplantation. Pediatr Nephrol. 2004;19:459.PubMedGoogle Scholar
  160. 160.
    Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, et al. Clinical course of polyomavirus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13:2145–51.PubMedGoogle Scholar
  161. 161.
    Johnston O, Jaswal D, Gill JS, Doucette S, Fergusson DA, Knoll GA. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation. 2010;89:1057–70.PubMedGoogle Scholar
  162. 162.
    Jeffs B. A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct. 2006;36:1–4.PubMedGoogle Scholar
  163. 163.
    Elling R, Henneke P, Hatz C, Hufnagel M. Dengue fever in children: where are we now? Pediatr Infect Dis J. 2013;32:1020–2.PubMedGoogle Scholar
  164. 164.
    Boonpucknavig V, Bhamarapravati N, Boonpucknavig S, Futrakul P, Tanpaichitr P. Glomerular changes in dengue hemorrhagic fever. Arch Pathol Lab Med. 1976;100:206–12.PubMedGoogle Scholar
  165. 165.
    Molyneux EM, Maitland K. Intravenous fluids–getting the balance right. N Engl J Med. 2005;353:941–4.PubMedGoogle Scholar
  166. 166.
    Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, Tran VD, Nguyen TH, Nguyen VC, Stepniewska K, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;353:877–89.PubMedGoogle Scholar
  167. 167.
    Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic fever. J Global Infect Dis. 2011;3:285–92.Google Scholar
  168. 168.
    Soares-Weiser K, Thomas S, Thomson G, Garner P. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis. 2010;10:207.PubMedCentralPubMedGoogle Scholar
  169. 169.
    Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G. Epidemiology of Hantavirus infections in humans: a comprehensive, global overview. Crit Rev Microbiol. 2014;40:261–72.PubMedGoogle Scholar
  170. 170.
    Manigold T, Vial P. Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology. Swiss Med Wkly. 2014;144:w13937.PubMedGoogle Scholar
  171. 171.
    Grcevska L, Polenakovic M, Oncevski A, Zografski D, Gligic A. Different pathohistological presentations of acute renal involvement in Hantaan virus infection: report of two cases. Clin Nephrol. 1990;34:197–201.PubMedGoogle Scholar
  172. 172.
    Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, et al. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res. 2009;81:68–76.PubMedGoogle Scholar
  173. 173.
    Allen CW, Alexander SI. Adenovirus associated haematuria. Arch Dis Child. 2005;90:305–6.PubMedCentralPubMedGoogle Scholar
  174. 174.
    Storsley L, Gibson IW. Adenovirus interstitial nephritis and rejection in an allograft. J Am Soc Nephrol. 2011;22:1423–7.PubMedCentralPubMedGoogle Scholar
  175. 175.
    Parasuraman R, Zhang PL, Samarapungavan D, Rocher L, Koffron A. Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient. Case Rep Transplant. 2013;2013:969186.PubMedCentralPubMedGoogle Scholar
  176. 176.
    Pasch A, Frey FJ. Coxsackie B viruses and the kidney–a neglected topic. Nephrol Dial Transplant. 2006;21:1184–7.PubMedGoogle Scholar
  177. 177.
    Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008;78:91–102.PubMedCentralPubMedGoogle Scholar
  178. 178.
    Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Baez C, Bassetti M, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395–404.PubMedGoogle Scholar
  179. 179.
    Lin CY, Hsu HC. Measles and acute glomerulonephritis. Pediatrics. 1983;71:398–401.PubMedGoogle Scholar
  180. 180.
    Kabakus N, Aydinoglu H, Bakkaloglu SA, Yekeler H. Mumps interstitial nephritis: a case report. Pediatr Nephrol. 1999;13:930–1.PubMedGoogle Scholar
  181. 181.
    Lin CY, Chen WP, Chiang H. Mumps associated with nephritis. Child Nephrol Urol. 1990;10:68–71.PubMedGoogle Scholar
  182. 182.
    Lau YL, Peiris JSM. Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol. 2005;17:404–10.PubMedGoogle Scholar
  183. 183.
    Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HW, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67:698–705.PubMedGoogle Scholar
  184. 184.
    Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, Faure P, Akhavan P, Low DE, Kain KC. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191:193–7.PubMedGoogle Scholar
  185. 185.
    Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622–30.PubMedGoogle Scholar
  186. 186.
    Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–4.PubMedGoogle Scholar
  187. 187.
    Eckerle I, Muller MA, Kallies S, Gotthardt DN, Drosten C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) coronavirus infection. Virol J. 2013;10:359.PubMedCentralPubMedGoogle Scholar
  188. 188.
    Giglioli G. Malaria and renal disease, with special reference to British Guiana. II The effect of malaria eradication on the incidence of renal disease in British Guiana. Ann Trop Med Parasitol. 1962;56:225–41.PubMedGoogle Scholar
  189. 189.
    Hendrickse RG, Gilles HM. The nephrotic syndrome and other renal diseases in children in Western Nigeria. East Afr Med J. 1963;40:186–201.PubMedGoogle Scholar
  190. 190.
    Ehrich JHH, Eke FU. Malaria-induced renal damage: facts and myths. Pediatr Nephrol. 2007;22:626–37.PubMedGoogle Scholar
  191. 191.
    Boonpucknavig V, Sitprija V. Renal disease in acute Plasmodium falciparum infection in man. Kidney Int. 1979;16:44–52.PubMedGoogle Scholar
  192. 192.
    Elsheikha HM, Sheashaa HA. Epidemiology, pathophysiology, management and outcome of renal dysfunction associated with plasmodia infection. Parasitol Res. 2007;101:1183–90.PubMedGoogle Scholar
  193. 193.
    Maitland K, Levin M, English M, Mithwani S, Peshu N, Marsh K, Newton CRJC. Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM. 2003;96:427–34.PubMedGoogle Scholar
  194. 194.
    Maitland K, Pamba A, Newton CRJC, Levin M. Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med. 2003;4:426–31.PubMedGoogle Scholar
  195. 195.
    Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483–95.PubMedGoogle Scholar
  196. 196.
    Van den Ende J, Coppens G, Verstraeten T, Van Haegenborgh T, Depraetere K, Van Gompel A, Van den Enden E, Clerinx J, Colebunders R, Peetermans WE, et al. Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health. 1998;3:632–9.PubMedGoogle Scholar
  197. 197.
    Barsoum RS. Schistosomiasis and the kidney. Semin Nephrol. 2003;23:34–41.PubMedGoogle Scholar
  198. 198.
    Seck SM, Sarr ML, Dial MC, Ka EF. Schistosoma haematobium-associated glomerulopathy. Indian J Nephrol. 2011;21:201–3.PubMedCentralPubMedGoogle Scholar
  199. 199.
    van Griensven J, Diro E. Visceral leishmaniasis. Infect Dis Clin North Am. 2012;26:309–22.PubMedGoogle Scholar
  200. 200.
    Caravaca F, Munoz A, Pizarro JL, Saez de Santamaria J, Fernandez-Alonso J. Acute renal failure in visceral leishmaniasis. Am J Nephrol. 1991;11:350–2.PubMedGoogle Scholar
  201. 201.
    Yap HK, Woo KT, Yeo PP, Chiang GS, Singh M, Lim CH. The nephrotic syndrome associated with filariasis. Ann Acad Med Singapore. 1982;11:60–3.PubMedGoogle Scholar
  202. 202.
    Graziani G, Cucchiari D, Verdesca S, Balzarini L, Montanelli A, Ponticelli C. Chyluria associated with nephrotic-range proteinuria: pathophysiology, clinical picture and therapeutic options. Nephron Clin Pract. 2011;119:c248–53; discussion c254.PubMedGoogle Scholar
  203. 203.
    Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis. 2009;13:125–33.PubMedGoogle Scholar
  204. 204.
    Gelman R, Brook G, Green J, Ben-Itzhak O, Nakhoul F. Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol. 2000;53:152–5.PubMedGoogle Scholar
  205. 205.
    Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 2014;28:61–74.PubMedGoogle Scholar
  206. 206.
    Stocker M, Caduff JH, Spalinger J, Berger TM. Successful treatment of bilateral renal fungal balls with liposomal amphotericin B and fluconazole in an extremely low birth weight infant. Eur J Pediatr. 2000;159:676–8.PubMedGoogle Scholar
  207. 207.
    Levin M, Hjelm M, Kay JD, Pincott JR, Gould JD, Dinwiddie R, Matthew DJ. Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet. 1983;2:64–7.PubMedGoogle Scholar
  208. 208.
    Levin M, Pincott JR, Hjelm M, Taylor F, Kay J, Holzel H, Dinwiddie R, Matthew DJ. Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr. 1989;114:194–203.PubMedGoogle Scholar
  209. 209.
    Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014;99:74–83.PubMedCentralPubMedGoogle Scholar
  210. 210.
    Watanabe T. Kidney and urinary tract involvement in Kawasaki disease. Int J Pediatr. 2013;2013:831834.PubMedCentralPubMedGoogle Scholar
  211. 211.
    Chaudhary R, Singh K, Jain N, Biswas R. Chronic flank pain, fever and an unusual diagnosis. BMJ Case Rep. 2011;2011. published online. doi: 10.1136/bcr.08.2011.4646.Google Scholar
  212. 212.
    Gupta G, Singh R, Kotasthane DS, Kotasthane VD, Kumar S. Xanthogranulomatous pyelonephritis in a male child with renal vein thrombus extending into the inferior vena cava: a case report. BMC Pediatr. 2010;10:47.PubMedCentralPubMedGoogle Scholar
  213. 213.
    Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C, Williams J, Schildgen O. Human Metapneumovirus: lessons learned over the first decade. Clinical Microbiology Reviews. 2011;24(4):734–754.Google Scholar
  214. 214.
    Allander T et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. PNAS. 2005;102(34):12891–6.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jennifer Stevens
    • 1
  • Jethro A. Herberg
    • 2
  • Michael Levin
    • 3
  1. 1.University Hospital WalesCardiffUK
  2. 2.Imperial College LondonLondonUK
  3. 3.Department of MedicineImperial College LondonLondonUK

Personalised recommendations